Global Neurological Disorder Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Neurological Disorder Diagnostics Market Growth (Status and Outlook) 2023-2029

Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.

LPI (LP Information)' newest research report, the “Neurological Disorder Diagnostics Industry Forecast” looks at past sales and reviews total world Neurological Disorder Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurological Disorder Diagnostics sales for 2023 through 2029. With Neurological Disorder Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disorder Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Neurological Disorder Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Disorder Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disorder Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disorder Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disorder Diagnostics.

The global Neurological Disorder Diagnostics market size is projected to grow from US$ 9859.1 million in 2022 to US$ 13200 million in 2029; it is expected to grow at a CAGR of 4.3% from 2023 to 2029.

United States market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neurological Disorder Diagnostics players cover Siemens, Philips, GE, Esaote, Masimo, Croton Healthcare and Neusoft, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disorder Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Imaging Techniques
In Vitro Diagnostics Techniques

Segmentation by application
Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Philips
GE
Esaote
Masimo
Croton Healthcare
Neusoft

Please note: The report will take approximately 2 business days to prepare and deliver.